Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 1
2010 1
2013 1
2014 1
2016 2
2018 2
2019 3
2020 3
2021 2
2022 2
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

17 results

Results by year

Filters applied: . Clear all
Page 1
Clinical Impact of RANK Signalling in Ovarian Cancer.
Wieser V, Sprung S, Tsibulak I, Haybaeck J, Hackl H, Fiegl H, Marth C, Zeimet AG. Wieser V, et al. Among authors: fiegl h. Cancers (Basel). 2019 Jun 8;11(6):791. doi: 10.3390/cancers11060791. Cancers (Basel). 2019. PMID: 31181781 Free PMC article.
Dubious effects of methadone as an "anticancer" drug on ovarian cancer cell-lines and patient-derived tumor-spheroids.
Fiegl H, Hagenbuchner J, Kyvelidou C, Seeber B, Sopper S, Tsibulak I, Wieser V, Reiser E, Roessler J, Huhtinen K, Carpén O, Parson W, Sprung S, Marth C, Ausserlechner MJ, Zeimet AG. Fiegl H, et al. Gynecol Oncol. 2022 Apr;165(1):129-136. doi: 10.1016/j.ygyno.2022.01.008. Epub 2022 Jan 13. Gynecol Oncol. 2022. PMID: 35033381 Free article.
The miR-34 family and its clinical significance in ovarian cancer.
Welponer H, Tsibulak I, Wieser V, Degasper C, Shivalingaiah G, Wenzel S, Sprung S, Marth C, Hackl H, Fiegl H, Zeimet AG. Welponer H, et al. Among authors: fiegl h. J Cancer. 2020 Jan 13;11(6):1446-1456. doi: 10.7150/jca.33831. eCollection 2020. J Cancer. 2020. PMID: 32047551 Free PMC article.
BRCA1 and BRCA2 mRNA-expression prove to be of clinical impact in ovarian cancer.
Tsibulak I, Wieser V, Degasper C, Shivalingaiah G, Wenzel S, Sprung S, Lax SF, Marth C, Fiegl H, Zeimet AG. Tsibulak I, et al. Among authors: fiegl h. Br J Cancer. 2018 Sep;119(6):683-692. doi: 10.1038/s41416-018-0217-4. Epub 2018 Aug 15. Br J Cancer. 2018. PMID: 30111871 Free PMC article.
17 results